E-LIB Suche - Ergebnisse für: Borghaei, H.

1

195MO Tarlatamab in previously treated small cell lung canc..:

Hummel, H-D. ; Champiat, S. ; Garcia, M.E. Olmedo...
ESMO Open. 9 (2024) - p. 102768 , 2024

Link: https://doi.org/10.1016/..

2

103TiP Sotorasib versus pembrolizumab in combination with p..:

Barlesi, F. ; Felip, E. ; Popat, S....
ESMO Open. 9 (2024) - p. 102682 , 2024

Link: https://doi.org/10.1016/..

3

EP11.03-35 Impact of KRAS Mutation Subtype and Comutations ..:

Sun, L. ; Handorf, E. ; Borghaei, H...
Journal of Thoracic Oncology. 18 (2023) 11 - p. S635-S636 , 2023

Link: https://doi.org/10.1016/..

4

P2.06-09 Association of Clinical Response and HRQoL with Lo..:

Reck, M. ; Worthy, G. ; Yuan, Y....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S320-S321 , 2023

Link: https://doi.org/10.1016/..

5

OA14.03 Six-year Survival and HRQoL Outcomes with 1L Nivolu..:

Ramalingam, S.S. ; Ciuleanu, T.-E. ; Bernabe Caro, R....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S76-S77 , 2023

Link: https://doi.org/10.1016/..

6

Long-term survival with first-line nivolumab plus ipilimuma..:

Borghaei, H. ; Ciuleanu, T.-E. ; Lee, J.-S....
Annals of Oncology. 34 (2023) 2 - p. 173-185 , 2023

Link: https://doi.org/10.1016/..

7

EP13.07-03 Treatment Patterns and Outcomes in Recent US Cli..:

Borghaei, H. ; Pundole, X. ; Anderson, E....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S706-S707 , 2023

Link: https://doi.org/10.1016/..

8

P2.17-01 Recent Patterns across Therapy Lines and Real-Worl..:

Borghaei, H. ; Shaw, J. ; Pundole, X....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S377-S378 , 2023

Link: https://doi.org/10.1016/..

9

Nivolumab plus chemotherapy in first-line metastatic non-sm..:

Borghaei, H. ; O'Byrne, K.J. ; Paz-Ares, L....
ESMO Open. 8 (2023) 6 - p. 102065 , 2023

Link: https://doi.org/10.1016/..

10

41P Efficacy of first-line (1L) nivolumab (N) + ipilimumab ..:

Borghaei, H. ; Balli, D. ; Paz-Ares, L....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S64-S65 , 2023

Link: https://doi.org/10.1016/..

11

EP01.01-23 Provider Perspectives on a Navigational Pilot St..:

Zawislak, C.L. ; Edmondson, D. ; Brecher, A....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S422 , 2023

Link: https://doi.org/10.1016/..

12

P2.07-04 Genomic Subtypes of EGFR-Mutant NSCLC and Real-Wor..:

Belani, N. ; Walzer, E. ; Deng, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S324 , 2023

Link: https://doi.org/10.1016/..

13

75TiP A multicenter, open-label, phase II trial evaluating ..:

Planchard, D. ; Paz-Ares, L. ; Spira, A....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S83-S84 , 2023

Link: https://doi.org/10.1016/..

14

P2.04-02 AVANZAR: Phase III Study of Datopotamab Deruxtecan..:

Aggarwal, C. ; Cheema, P. ; Arrieta, O....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S305-S306 , 2023

Link: https://doi.org/10.1016/..

15

MA04.10 Molecular Characteristics of Non-Small Cell Lung Ca..:

Zaemes, J. ; Tolulope, A. ; Elliott, A....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S112-S113 , 2023

Link: https://doi.org/10.1016/..